Get Smart: Leveraging New Technologies to Optimize Diabetes Management

Learn about current and emerging digital technology to help better manage patients on insulin therapy by improving A1C/time in range, identifying hypoglycemia, and increasing adherence.
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP
Anne Peters, MD
Jennifer Sherr, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.99 MB
Released: November 12, 2021

Acknowledgements

Provided by Endocrine Society

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.

Related Content

Concise microlearning module featuring expert insight on the cardiorenal benefits of finerenone in T2D and CKD from Clinical Care Options (CCO)

Vivian A. Fonseca, MD, FRCP
Program Director
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: August 4, 2022 Expired: August 3, 2023

Commentary on clinical use of SGLT2 inhibitors in diabetic kidney disease, from Clinical Care Options (CCO)

Jennifer B. Green, MD Released: July 21, 2022

Concise microlearning module featuring expert insight on the cardiorenal benefits of SGLT2 inhibitors in T2D from Clinical Care Options (CCO)

Jennifer B. Green, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: July 12, 2022 Expired: July 11, 2023

Unlocked downloadable slides featuring an overview of the cardiorenal benefits of SGLT2 inhibitors in patients with type 2 diabetes, from Clinical Care Options (CCO)

Jennifer B. Green, MD Released: July 12, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings